Loading…
Reported covered position: Staff Assistant; Deputy Scheduler for Sen Joe Donnelly (IN-2)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2026 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Source: Senate LDA
| FUTURE OF PHARMACY COALITION |
| 2 |
| 2022 |
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2026 · third_quarter · Q3
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2026 · third_quarter · Q3
Legislation and other proposed policy change impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2026 · third_quarter · Q3
Advocate for access to affordable therapies and technology, including legislative efforts to reduce the cost of insulin.
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to health insurance coverage through Medicaid and the Affordable Care Act.
Advocate for access to healthy food for people with diabetes.
Funding for programs and research relevant for people with diabetes.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2026 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2026 · second_quarter · Q2
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2026 · second_quarter · Q2
Advocate for access to affordable therapies and technology, including legislative efforts to reduce the cost of insulin.
Funding for programs and research relevant for people with diabetes.
Advocate for access to healthy food for people with diabetes.
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2026 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2026 · first_quarter · Q1
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2026 · first_quarter · Q1
Advocate for access to healthy food for people with diabetes.
Funding for programs and research relevant for people with diabetes.
Advocate for access to affordable therapies and technology, and efforts to preserve access to health care coverage for people with diabetes and prediabetes.
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2025 · fourth_quarter · 4A
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2025 · fourth_quarter · 4A
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to health insurance coverage through Medicaid and the Affordable Care Act.
Funding for programs and research relevant for people with diabetes.
Advocate for access to affordable therapies and technology, and efforts to preserve access to health care coverage for people with diabetes and prediabetes.
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2025 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2025 · fourth_quarter · Q4
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2025 · fourth_quarter · Q4
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to health insurance coverage through Medicaid and the Affordable Care Act.
Advocate for access to affordable therapies and technology, and efforts to preserve access to health care coverage for people with diabetes and prediabetes.
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2025 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2025 · third_quarter · 3T
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2025 · third_quarter · Q3
Legislation and other proposed policy change impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2025 · third_quarter · Q3
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to health insurance coverage through Medicaid and the Affordable Care Act.
Funding for programs and research relevant for people with diabetes.
Advocate for access to affordable therapies and technology, and efforts to preserve access to health care coverage for people with diabetes and prediabetes.
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2025 · third_quarter · Q3
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2025 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2025 · second_quarter · Q2
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2025 · second_quarter · Q2
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2025 · second_quarter · Q2
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to health insurance coverage through Medicaid and the Affordable Care Act, and measures to prevent amputation.
Funding for programs and research relevant for people with diabetes.
Advocate for access to affordable therapies and technology, and efforts to preserve access to health care coverage for people with diabetes and prediabetes.
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2025 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2025 · first_quarter · Q1
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Volunteer Income Tax Assistance (VITA), and Child Tax Credit.
Support for nutrition programs in the farm bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2025 · first_quarter · Q1
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Funding for programs and research relevant for people with diabetes.
Advocate for access to affordable therapies and technology.
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2024 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2024 · fourth_quarter · Q4
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Volunteer Income Tax Assistance (VITA), and Child Tax Credit.
Support for nutrition programs in the farm bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2024 · fourth_quarter · Q4
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Funding for programs and research relevant for people with diabetes.
Advocate for access to healthy food for people with diabetes.
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2024 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2024 · third_quarter · Q3
Support for nutrition programs in the farm bill.
Volunteer Income Tax Assistance (VITA), and Child Tax Credit.
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Filing targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2024 · third_quarter · Q3
Legislation and other proposed policy change impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2024 · third_quarter · Q3
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Funding for programs and research relevant for people with diabetes.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2024 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2024 · second_quarter · Q2
Support for nutrition programs in the farm bill.
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Volunteer Income Tax Assistance (VITA), and Child Tax Credit.
Filing targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2024 · second_quarter · Q2
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2024 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2024 · first_quarter · Q1
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Filing targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2024 · first_quarter · Q1
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
UNITED WAY WORLDWIDE via VENN STRATEGIES
2023 · fourth_quarter · Q4
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Filing targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · fourth_quarter · Q4
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Funding for programs and research relevant for people with diabetes.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2023 · third_quarter · Q3
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Filing targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · third_quarter · Q3
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2023 · third_quarter · Q3
Legislation and other proposed policy change impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Natl Economic Council (NEC), SENATE, Treasury, Dept of
UNITED WAY WORLDWIDE via VENN STRATEGIES
2023 · second_quarter · Q2
Support for 211 line and Human-Services Emergency Logistics Program (HELP) Act.
Filing targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · second_quarter · Q2
Healthcare policies affecting Americans living with diabetes.
Funding for programs and research relevant for people with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · first_quarter · 1A
Healthcare policies affecting Americans living with diabetes.
Funding for programs and research relevant for people with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · first_quarter · Q1
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · fourth_quarter · 4A
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · third_quarter · 3A
Healthcare policies affecting Americans living with diabetes.
Funding for programs and research relevant for people with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · fourth_quarter · 4A
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · third_quarter · 3A
Healthcare policies affecting Americans living with diabetes.
Funding for programs and research relevant for people with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · fourth_quarter · Q4
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FUTURE OF PHARMACY COALITION via VENN STRATEGIES
2022 · fourth_quarter · 4T
Ensuring access to vital pharmacist services.
Ensuring access to vital pharmacist services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FUTURE OF PHARMACY COALITION via VENN STRATEGIES
2022 · third_quarter · Q3
Ensuring access to vital pharmacist services.
Ensuring access to vital pharmacist services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · third_quarter · Q3
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2022 · third_quarter · Q3
Legislation impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · second_quarter · Q2
Healthcare policies affecting Americans living with diabetes.
Funding for programs and research relevant for people with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · first_quarter · Q1
Healthcare policies affecting Americans living with diabetes.
Funding for programs and research relevant for people with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS via VENN STRATEGIES
2021 · fourth_quarter · 4T
Advocating for policies that will increase the ability of pharmacists to serve patients.
Advocating for policies that will increase the ability of pharmacists to serve patients.
Advocating for policies that will increase the ability of pharmacists to serve patients.
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2021 · fourth_quarter · Q4
Funding for programs and research relevant for people with diabetes.
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS via VENN STRATEGIES
2021 · third_quarter · Q3
Advocating for policies that will increase the ability of pharmacists to serve patients.
Advocating for policies that will increase the ability of pharmacists to serve patients.
Advocating for policies that will increase the ability of pharmacists to serve patients.
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to health insurance coverage through Medicaid and the Affordable Care Act.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to health insurance coverage through Medicaid and the Affordable Care Act.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Advocate for access to healthy food for people with diabetes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Advocate for access to healthy food for people with diabetes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Advocate for access to healthy food for people with diabetes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Advocate for access to healthy food for people with diabetes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Advocate for access to healthy food for people with diabetes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Advocate for access to affordable therapies and technology.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Advocating for policies that will increase the ability of pharmacists to serve patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
Advocating for policies that will increase the ability of pharmacists to serve patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services, Dept of (HHS)